Show simple item record

dc.contributor.author Maldonado, Rafael, 1961-
dc.contributor.author Calvé Pérez, Pablo, 1993-
dc.contributor.author García Blanco, Alejandra
dc.contributor.author Domingo Rodriguez, Laura, 1992-
dc.contributor.author Senabre, Eric
dc.contributor.author Martín García, Elena, 1975-
dc.date.accessioned 2021-08-27T08:13:35Z
dc.date.issued 2021
dc.identifier.citation Maldonado R, Calvé P, García-Blanco A, Domingo-Rodriguez L, Senabre E, Martín-García E. Genomics and epigenomics of addiction. Am J Med Genet B Neuropsychiatr Genet. 2021;186(3):128-39. DOI: 10.1002/ajmg.b.32843
dc.identifier.issn 1552-4841
dc.identifier.uri http://hdl.handle.net/10230/48337
dc.description.abstract Recent progress in the genomics and epigenomics of addiction has contributed to improving our understanding of this complex mental disorder's etiology, filling the gap between genes, environment, and behavior. We review the behavioral genetic studies reporting gene and environment interactions that explain the polygenetic contribution to the resilience and vulnerability to develop addiction. We discuss the evidence of polymorphic candidate genes that confer susceptibility to develop addiction as well as the studies of specific epigenetic marks that contribute to vulnerability and resilience to addictive-like behavior. A particular emphasis has been devoted to the miRNA changes that are considered potential biomarkers. The increasing knowledge about the technology required to alter miRNA expression may provide promising novel therapeutic tools. Finally, we give future directions for the field's progress in disentangling the connection between genes, environment, and behavior.
dc.format.mimetype application/pdf
dc.language.iso eng
dc.publisher Wiley
dc.relation.ispartof Am J Med Genet B Neuropsychiatr Genet. 2021;186(3):128-39
dc.rights This is the peer reviewed version of the following article: Maldonado R, Calvé P, García-Blanco A, Domingo-Rodriguez L, Senabre E, Martín-García E. Genomics and epigenomics of addiction. Am J Med Genet B Neuropsychiatr Genet. 2021;186(3):128-39. doi: 10.1002/ajmg.b.32843, which has been published in final form at http://dx.doi.org/10.1002/ajmg.b.32843. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
dc.title Genomics and epigenomics of addiction
dc.type info:eu-repo/semantics/article
dc.identifier.doi http://dx.doi.org/10.1002/ajmg.b.32843
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.type.version info:eu-repo/semantics/acceptedVersion

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics

In collaboration with Compliant to Partaking